guest ::
Marketing authorization applications made to the european medicines agency in 2018–2019: what was the contribution of real-world evidence?
; ; ; ; ; ; ; ;
In
Clinical pharmacology & therapeutics 111(1), Seiten/Artikel-Nr.:90-97
2021
First published: 24 October 2021
Online
DOI: 10.18154/RWTH-CONV-250487
DOI: 10.1002/cpt.2461
URL: https://publications.rwth-aachen.de/record/889388/files/889388.pdf
Einrichtungen
OpenAccess: 
PDF
Dokumenttyp
Journal Article
Format
online, print
Sprache
English
Anmerkung
Peer reviewed article
Externe Identnummern
SCOPUS: SCOPUS:2-s2.0-85118938988
WOS Core Collection: WOS:000727322700001
PubMed: pmid:34689339
Interne Identnummern
RWTH-CONV-250487
Datensatz-ID: 889388
Beteiligte Länder
Germany, Netherlands, UK
; 
; 
; BIOSIS Previews ; Biological Abstracts ; Clarivate Analytics Master Journal List ; Current Contents - Clinical Medicine ; Current Contents - Life Sciences ; DEAL Wiley ; Essential Science Indicators ; IF >= 5 ; JCR ; SCOPUS ; Science Citation Index Expanded ; Web of Science Core Collection
|
The record appears in these collections: |
PDF